Error message
You must have JavaScript and cookies enabled in your browser to flag content.
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Dr. McAneny's broad expertise and insight on today’s challenging health care environment will greatly benefit the practice of medicine and our patients.
Preparing for the future starts with gaining clarity about the present state of oncology care. Our goal is for practices in all settings across the U.S. to provide feedback in the 2017 ASCO Practice Census.
If you say things of consequence, there may be consequences; but the alternative is to be inconsequential. Particularly in these tumultuous times for health care and research, we need to speak up!
Mr. Harvey D. Bichkoff offers a firsthand perspective of MACRA implementation at Marin Cancer Care, the private practice for which he serves as CEO.
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these...
Sustaining this progress described in this report will be determined in large part by the level of federal investment in our nation's biomedical research enterprise.
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Pages